EGFR and non-small cell lung carcinoma: To dissect the underlying mechanisms of the TKI resistance conferred by secondary EGFR-T790M mutation, we applied AP-MS strategy to construct the EGFR interactome atlas in two TKI-sensitive NSCLC cell lines and their corresponding TKI-resistant NSCLC cell lines (Fig. 1).